Takeda Pharmaceutical Company Limited Current Tax Expense Income
Takeda Pharmaceutical Company Limited (TAK) reported Current Tax Expense Income of JPY 138.06 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:CurrentTaxExpenseIncome · last filed 2025-06-25
| Period end | Current Tax Expense Income 12 month |
|---|---|
| 2025-03-31 | 138.06B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 107.35B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 246.58B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 208.51B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 131.95B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | 238.86B JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | 61.61B JPY 20-F · filed 2021-06-29 |
| 2018-03-31 | 37.76B JPY 20-F · filed 2020-06-24 |
| 2017-03-31 | 60.24B JPY 20-F · filed 2019-06-27 |